Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             183 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 166 O - A monoclonal antibody developed against candida albicans antigens cross-reacts with human ovarian carcinomas Schneider, J.
 1996
 32 S1 p. S33-
1 p.
 artikel
2 79 O - An approach for evaluating the cost-effectiveness and impact on quality of life of inpatient treatment versus outpatient trea1ment during consolidation chemotherapy in elderly patients with acute myeloid leukemia (AML) Kiebert, W.
 1996
 32 S1 p. S15-
1 p.
 artikel
3 157 O - A new approach to refractory carcinoma of the prostate: microtubular inhibition with estramustine and vinorelbin Morgia, Giuseppe
 1996
 32 S1 p. S31-
1 p.
 artikel
4 163 O - Aortic infuslon (ADM, MMC, CDDP) and stop-flow (MMC, ADM) for systemically pretreated and progresslve FLGO III c and IV ovarian cancer-45 patients Gailhofer, S.
 1996
 32 S1 p. S32-
1 p.
 artikel
5 122 O - A phase I trial of epirubicin (E) and paclitaxel (P) in patients with metastatic breast cancer (MBC) Salyadori, R.
 1996
 32 S1 p. S24-
1 p.
 artikel
6 177 O - A prospective randomized trial on neoadjuvant and adjuvant chemo- and radiotherapy in primarily inoperable soft tissue sarcoma Zielinski, C.C.
 1996
 32 S1 p. S35-
1 p.
 artikel
7 151 O - Association between helicobacter pylori infection and pancreatic cancer Theyer, U.
 1996
 32 S1 p. S29-
1 p.
 artikel
8 117 O - Axillary node sampling in breast cancer: an assessment of its efficacy Ravi Sekar, O.
 1996
 32 S1 p. S23-
1 p.
 artikel
9 28 O - Batimastat potentiates cisplatin activity on humanovarian carcinoma xenografts Nicoletti, M.I.
 1996
 32 S1 p. S6-
1 p.
 artikel
10 80 O - Bone marrow transplantation in children: low risk in different total body irradiation regimens Torretta, A.
 1996
 32 S1 p. S16-
1 p.
 artikel
11 18 O - Characterization of a protein which recognizes DNA damaged by minor groove binders Colella, G.
 1996
 32 S1 p. S4-
1 p.
 artikel
12 113 O - Conservative treatment of early breast cancer Paroconnaya, A.
 1996
 32 S1 p. S22-
1 p.
 artikel
13 138 O - Detection of colorectal carcinoma metastases in blood Denis, M.G.
 1996
 32 S1 p. S27-
1 p.
 artikel
14 35 O Does neoadjuvant npv (nitomycin c, cisplatin. vinblastine) chemothbrapy increase to risk of bronchopleural fistulas? Chiesa, G.
 1996
 32 S1 p. S7-
1 p.
 artikel
15 124 o - Does timing of surgery for breast cancer affect prognosis? Skuladottir, H.
 1996
 32 S1 p. S24-
1 p.
 artikel
16 24 O - Ecteinascidin-743 (ET743) : in vitro (IVT) and in vivo (INY) results in solid tumor models Faircloth, G.
 1996
 32 S1 p. S5-
1 p.
 artikel
17 89 O - Effecf of previous adjuvant chemotherapy on the activity and efficacy of cef regimen in metastatic breast cancer patients Del Mastro, L.
 1996
 32 S1 p. S18-
1 p.
 artikel
18 147 O - Effect of preoperative hyperthermia with radio-chemo-therapy on resectability of locally advanced rectal cancer. A phase II clinical Rau, B.
 1996
 32 S1 p. S28-
1 p.
 artikel
19 57 O - Epidemiological aspects of lung cancer in greece Zaharof, A.K.
 1996
 32 S1 p. S11-
1 p.
 artikel
20 1 O - Experimental malignant conversion of early stage human melanoma cells: evidence for a dominant phenotype Bani, M.R.
 1996
 32 S1 p. S1-
1 p.
 artikel
21 10 O - Expression of inducible nitric oxide synthase mRNA in human tumor-associated macrophages Pedram, E.
 1996
 32 S1 p. S2-
1 p.
 artikel
22 37 O - Fluorescence bronchoscopy in early detection of lung cancer Dal Fante, M.
 1996
 32 S1 p. S8-
1 p.
 artikel
23 167 O - Gm-csf and interferon-γ modulate cytotoxicity and cytokine production of malignant effusion - derived macrophages Zavadova, E.
 1996
 32 S1 p. S33-
1 p.
 artikel
24 181 O - HIV-related cervical cancer (CA) in Italy; a report of 54 cases from the Italian cooperative group on aids and tumors (GICAT) Santarossa, S.
 1996
 32 S1 p. S37-
1 p.
 artikel
25 69 O - Idarubicin vs mitoxantrone in a continous-infusion cyclophosphamide plus dexamethasone regimen for adyanced refractory myeloma Nozzoli, C.
 1996
 32 S1 p. S14-
1 p.
 artikel
26 137 O - Induction of a heat shock response protects tumour cells from monocyte mediated lysis Campbell, F.
 1996
 32 S1 p. S27-
1 p.
 artikel
27 175 O - Induction of immunomediated diseases by recombinant human granulocytemacrophage colony-stimulating factor during cancer treatment Locker, G.J.
 1996
 32 S1 p. S35-
1 p.
 artikel
28 143 O - Inoperable liver metastases from colo-rectal cancer treated by systemic or loco-regional chemotherapy Massidda, B.
 1996
 32 S1 p. S28-
1 p.
 artikel
29 154 O - Intermediate analysis at minimum 5 years follow-up of 70 patients with prostate cancer treated by external beam and brachytherapy Galalae, R.
 1996
 32 S1 p. S30-
1 p.
 artikel
30 6 O - Intrinsic multidrug resistance-associated protein in human malignant melanoma cell lines Hauptmann, E.
 1996
 32 S1 p. S2-
1 p.
 artikel
31 153 O - In vitro electromotive administration of mitomycin C in human bladder wall Di Stasi, S.M.
 1996
 32 S1 p. S30-
1 p.
 artikel
32 15 O - Isolation of an estrogen receptor variant with increased activity from premalignant breast lesions Wiltschke, C.
 1996
 32 S1 p. S3-
1 p.
 artikel
33 116 O - Large core breast biopsy: a pre-operative tool in breast cancer prognosis Puglisi, F.
 1996
 32 S1 p. S23-
1 p.
 artikel
34 50 O - Loss of heterozygosity (LOH) AT 5q21 and prognosis in resected non-small cell lung cancer (NSCLC) Sánchez, M.
 1996
 32 S1 p. S10-
1 p.
 artikel
35 142 O - Loss of heterozygosity (LOH) at 18q and 5q and survival in dukes’ stage B colorectal cancer Martínez, E.
 1996
 32 S1 p. S28-
1 p.
 artikel
36 110 O - Magnetic resonance imaging guided minimally invasive treatment of breast cancer Mumtaz, H.
 1996
 32 S1 p. S22-
1 p.
 artikel
37 68 O - Maintenance low-dose (LD) oral idarubicin (oIDA) in elderly patients (pts) with acute myelogeneous leukemia (AML) Musso, M.
 1996
 32 S1 p. S14-
1 p.
 artikel
38 173 O - Management of clinically positive axillary or inguinal lymph nodes in patients with malignant melanoma-A decision analysis Kittler, H.
 1996
 32 S1 p. S35-
1 p.
 artikel
39 140 O - Molecular analysis of APC mutations in familial adenomatous polyposis De Rosa, M.
 1996
 32 S1 p. S27-
1 p.
 artikel
40 14 O - New mutation in BRCA 1 gene detected in 3 austrian HBOC families Wagner, T.
 1996
 32 S1 p. S3-
1 p.
 artikel
41 132 O - Oral adjuvant chemotherapy in stage II (B2-3) and III (C) colon cancer Abad, A.
 1996
 32 S1 p. S26-
1 p.
 artikel
42 20 O - Oxaliplatin (L-OHP) in fluorouracil (FU) refractory patients with metastallc colorectal cancer Nolè, F.
 1996
 32 S1 p. S5-
1 p.
 artikel
43 44 O - Preventive oncology and nicotine addiction: a hypothesis Kunze, U.
 1996
 32 S1 p. S9-
1 p.
 artikel
44 70 O - Prognostic pactors in acute leukemias Ozyilkan, E.
 1996
 32 S1 p. S14-
1 p.
 artikel
45 133 O - Prognostic significance of the nm23-H1 protein expression in colorectal cancer Abad, A.
 1996
 32 S1 p. S26-
1 p.
 artikel
46 158 O - PSA doubling time after brachytherapy with I-125 for prostatic carcinoma category T1c-3G1-3N0M0 Schipper, R.A.
 1996
 32 S1 p. S31-
1 p.
 artikel
47 160 O - Quality of life assessment in patients with prostatic carcinoma category T1-3 N1-3 MO, receiving or not receiving hormonal treatment Van Andel, G.
 1996
 32 S1 p. S31-
1 p.
 artikel
48 162 O Randomized study of cyclophosphamide, doxorubicin & cisplatin (CAP) vs single agent carboplatin in ovarian cancer patients requiring chemotherapy: Interim results of ICON2 Crook, A.
 1996
 32 S1 p. S32-
1 p.
 artikel
49 3 O - Reentry into the cell cycle of live-irradiated quiescent normal human diploid fibroblasts: its relationships with p53 induction or inhibition Cćraline, J.
 1996
 32 S1 p. S1-
1 p.
 artikel
50 7 O - Relationship to multidrug resistance of the transporter associated with antigen presentation tap. Izquierdo, M.A.
 1996
 32 S1 p. S2-
1 p.
 artikel
51 17 O - Role of antiestrogens as antifribotic agents Cagini, L.
 1996
 32 S1 p. S4-
1 p.
 artikel
52 64 O - Second malignant neoplasms after hodgkin's disease (HD): an analysis of 1531 patients (PTS) treated in florence (1960–1991) Magrini, S.M.
 1996
 32 S1 p. S13-
1 p.
 artikel
53 74 O - Selective anti-leukemic potential of HLA-incompatible bone marrow transplants Ruggeri, Loredana
 1996
 32 S1 p. S15-
1 p.
 artikel
54 106 O - Sitam-01 adjuvant breast trial for patients > 50 years Belfiglio, M.
 1996
 32 S1 p. S21-
1 p.
 artikel
55 58 O - Successful engraftment of t-cell-depleted HLA-incompatible transplants Aversa, F.
 1996
 32 S1 p. S12-
1 p.
 artikel
56 98 O - Tamoxifen +/- short-term chemotherapy in the treatment of node positive, hormone receptor positive breast cancer: 7-year results of a randomized trial including 517 patients Jakesz, R.
 1996
 32 S1 p. S20-
1 p.
 artikel
57 22 O - Taurine enhances macrophage-mediated cytotoxicity via increased arginase release Duggan, S.
 1996
 32 S1 p. S5-
1 p.
 artikel
58 51 O The alpi trial: a randomized study of adjuvant chemotherapy for stage I-II-IIIA non-small cell lung cancer (NSCLC) Scagliotti, G.
 1996
 32 S1 p. S10-
1 p.
 artikel
59 23 O - The anti-tumour efficacy of taurine and recombinant interleukin-2 in vivo Finnegan, N.
 1996
 32 S1 p. S5-
1 p.
 artikel
60 156 O - The correlation between pepsinogen II immunoreactivity, Ulex Europaeus staining and survival in patients with prostate cancer Lovisolo, J.A.
 1996
 32 S1 p. S30-
1 p.
 artikel
61 46 O - The role of vats (videothoracoscopy) in the staging of lung cancer Manzini, L.
 1996
 32 S1 p. S9-
1 p.
 artikel
62 134 O - The S.M.A.C. study: large scale collaborative trial of adjuvant therapy in colon cancer Alexanian, A.
 1996
 32 S1 p. S26-
1 p.
 artikel
63 59 O - Thiotepa improves results of t-cell-depleted bone marrow tranplants for acute leukemia. a seven year experience Aversa, F.
 1996
 32 S1 p. S12-
1 p.
 artikel
64 21 O - Treatment of pig experimental cholangiocarcinoma by 5-fluoro-2-deoxyuridine conjugates: a comparative study Dufek, V.
 1996
 32 S1 p. S5-
1 p.
 artikel
65 8 O - Tumor cells transfected with HSP27 heat shock protein show modification in proliferation and tumorigenicity Kindas-Mügge, I.
 1996
 32 S1 p. S2-
1 p.
 artikel
66 161 O - Very high-dose chemotherapy (VHDCT) with ematologic support in previously untreated advanced ovarian cancer (OVCA): preliminary results of a phase I-II study Benedetti-panici, P.
 1996
 32 S1 p. S32-
1 p.
 artikel
67 42 P - Activity of cathepsin D in non small cell lung cancer Ploński, A.
 1996
 32 S1 p. S9-
1 p.
 artikel
68 54 P - A60-Elisa test in diagnosing of lung tumours Siemińska, A.
 1996
 32 S1 p. S11-
1 p.
 artikel
69 183 P - Age and LDH are independent prognostic factors also in HIV-related non-hodgkin's lymphoma (HIV-NHL): a monoinstitutional study of 96 patients (pts) Vaccher, E.
 1996
 32 S1 p. S38-
1 p.
 artikel
70 114 P - Aminoacylation of mitochondrial tRNA from breast cancer tissue Pasternak, K.
 1996
 32 S1 p. S22-
1 p.
 artikel
71 33 P - A model to assess cost-effectiveness of prophylaxis of febrile neutropenia Bussels, J.
 1996
 32 S1 p. S7-
1 p.
 artikel
72 36 P A phase II study of epirubicin in combination therapy of small cell lung cancer (SCLC) Damianov, D.
 1996
 32 S1 p. S8-
1 p.
 artikel
73 9 P - A Possible mechanism of P-glycoprotein regulation in P-388 leukaemia cells Kuznet sovs, SJ
 1996
 32 S1 p. S2-
1 p.
 artikel
74 178 P - A randomized trial of adjuvant treatment of soft tissue sarcomas by either radiotherapy or radiotherapy + ifosfamide, adriblastin and DTIC (IFADIC) intensified by the use of G-CSF Zielinski, C.
 1996
 32 S1 p. S36-
1 p.
 artikel
75 78 P - A retrospective analysis of 34 patients with primary gastrointestinal non-hodgkin's lymphoma Szabó, F.
 1996
 32 S1 p. S15-
1 p.
 artikel
76 90 P - Association Of Lactosamine Type 2 Oligosaccharide Structures with MUC-1 Apomucin in the Human Breast Cancer Cell Line SKBR5 Dettke, M.
 1996
 32 S1 p. S18-
1 p.
 artikel
77 87 P - Biological indications to surgical treatment for early breast cancer Zanon, C.
 1996
 32 S1 p. S18-
1 p.
 artikel
78 34 P - Blood vessel invasion by tumor cells and tumor angiogenesis could predict recurrence in resected non shall cell lung cancer Chiesa, G.
 1996
 32 S1 p. S7-
1 p.
 artikel
79 109 P - Brachytherapy for Breast Cancer špikalovas, V.
 1996
 32 S1 p. S22-
1 p.
 artikel
80 123 P - Breast and colo-rectal cancer in Europe: problems related to collection and analysis of dietary data Salyini, S.
 1996
 32 S1 p. S24-
1 p.
 artikel
81 125 P - Breast cancer patients generalized at diagnosis have a significantly better response to polychemotherapy than those with relapse after curative surgery Steger, G.G.
 1996
 32 S1 p. S24-
1 p.
 artikel
82 130 P - Breast conservation without axillary dissection Zurrida, S.
 1996
 32 S1 p. S25-
1 p.
 artikel
83 82 P - CAl5.3: A breast cancer marker predicting location of metastases even before treatment Barrenetxea, G.
 1996
 32 S1 p. S17-
1 p.
 artikel
84 88 P - Carboplatin, Etoposide Plus UFT Modulated By Orally Leucovorin Low Dose Schedule (FLEE) In Metastatic Breast Cancer (MBE) Danlels, M.
 1996
 32 S1 p. S18-
1 p.
 artikel
85 102 P - CEF ± G-CSF As primary chemotherapy (PCT) in ≥ 3cm breast cancer (BC) patients(PTS) Conti, F.
 1996
 32 S1 p. S20-
1 p.
 artikel
86 100 P - Cell Proliferation Of Breast Cancer as a Marker of Radio- and Chemoendocrine Sensibility Koshelev, S.V.
 1996
 32 S1 p. S20-
1 p.
 artikel
87 120 P - Chemoprevention of breast cancer: update of the Italian trial in hysterectomised women Sacchini, V.
 1996
 32 S1 p. S23-
1 p.
 artikel
88 165 P - Chemotherapy in adyanced oyarian cancer Płuzańska, A.
 1996
 32 S1 p. S33-
1 p.
 artikel
89 16 P Chemotherapy induced emesis. management of early and delayed emesis in milder emetogenic regimens Barrenetxea, G.
 1996
 32 S1 p. S4-
1 p.
 artikel
90 39 P - Chemotherapy induced leukopenia as a predictor of response in small cell lung cancer (SCLC) Jereczek, B.
 1996
 32 S1 p. S8-
1 p.
 artikel
91 62 P - CIP regimen as consolidation therapy after P-VABEC in aggressive NHL of the elderly Caracciolo, F.
 1996
 32 S1 p. S13-
1 p.
 artikel
92 180 P - Clinico-pathologic correlations in 120 patients (PTS) with HIV-related-systemicnon-hodgkin's lymphoma (HIV-NHL): A monoinstitutional study Nasti, G.
 1996
 32 S1 p. S37-
1 p.
 artikel
93 144 P - Colonoscopic characteristics of synchronious colorectal carcinomas Nagorni, A.
 1996
 32 S1 p. S28-
1 p.
 artikel
94 131 P - Combination of cisplatin, epirubicin and ftorafur for breast cancer Zagrekova, E.
 1996
 32 S1 p. S25-
1 p.
 artikel
95 139 P - Combined radiochemotherapy in patients with locally advanced pancreatic cancer (PC) Hejna, M.
 1996
 32 S1 p. S27-
1 p.
 artikel
96 38 P - Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumor markers in lung cancer Huang, Ming-Shyan
 1996
 32 S1 p. S8-
1 p.
 artikel
97 61 P - Comprehensive geriatric assessment: a new approach to assess the global health status of elderly patients with cancer to be entered in clinical trials Bordonaro, R.
 1996
 32 S1 p. S12-
1 p.
 artikel
98 32 P - Correlations between DNA ploidy and immunophenotype of lymphocytes from malignant pleurae effusions Sikora, J.
 1996
 32 S1 p. S7-
1 p.
 artikel
99 96 P - Elevated vascular endothelial growth factor in breast cancer Harmey, J.H.
 1996
 32 S1 p. S19-
1 p.
 artikel
100 182 P - Epirubicin, bleomycin, vinblastine and prednisone (EBVP) chemotherapy (CT) in combination with antiretroviral therapy and primary use of G-CSF for patients (pts) with hodgkin's disease and HIV infection (HD-HIV) Tirelli, U.
 1996
 32 S1 p. S37-
1 p.
 artikel
101 81 P - Epirubicin (EPI) + navelbine (NVB) as first line chemotherapy in advanced breast cancer (ABC) patients (PTS): a multicentric phase II study Baldini, E.
 1996
 32 S1 p. S17-
1 p.
 artikel
102 128 P - Epirubicin intermediate dose plus cyclophosphamide in the treatment of metastatic breast cancer (MBC) Trotti, G.
 1996
 32 S1 p. S25-
1 p.
 artikel
103 150 P - Expression of the drug resistance genes MDR1, MRP, GSTπ and MT2A in human primary gastric carcinomas Suchomel, R.W.
 1996
 32 S1 p. S29-
1 p.
 artikel
104 146 P - Familiarity and counselling in hereditary colorectal cancer Pozzi, S.
 1996
 32 S1 p. S28-
1 p.
 artikel
105 136 P - Feasibility and activity of a 3-day pelf-like regimen in advanced gastric cancer. Preliminary data Crivellari, D.
 1996
 32 S1 p. S27-
1 p.
 artikel
106 11 P - Frequent Loss of Heterozygosity at 6q in Malignant Salivary Gland Tumors Queimado, L.
 1996
 32 S1 p. S3-
1 p.
 artikel
107 49 P - Frequent replication errors at microsatellite loci on chromosomes 2p and 3p in non-small cell lung cancer Pifarré, A.
 1996
 32 S1 p. S10-
1 p.
 artikel
108 29 P - Gemcitabine: an active well tolerated drug for advanced non small cell lung cancer (NSCLC) de Braud, F.
 1996
 32 S1 p. S6-
1 p.
 artikel
109 169 P - Glutatiflon (GSH) for protection of cisplatinum (CDDP) induced neuro- and nephrotoxicity Djavanmard, M.P.
 1996
 32 S1 p. S34-
1 p.
 artikel
110 121 P - Hepatosteatosis and alterations of CA15.3 and CEA in patients with breast cancer receiving tamoxifen Sahin, B.
 1996
 32 S1 p. S24-
1 p.
 artikel
111 108 P - Histological and clinical response evaluation to primary chemotherapy in local - advanced breast cancers Miron, L.
 1996
 32 S1 p. S21-
1 p.
 artikel
112 53 P - Ifosfamide, cisplatin and etoposide (ICE) combination in locally advanced non small cell lung cancer (NSCLC): a phase II study Scinto, A.F.
 1996
 32 S1 p. S10-
1 p.
 artikel
113 71 P - Immune profile in chronic lymphocytic leukemia Paydas, S.
 1996
 32 S1 p. S14-
1 p.
 artikel
114 31 P - Immunolymphoscintigraphy and sentinel node biopsy in melanoma Testori, A.
 1996
 32 S1 p. S6-
1 p.
 artikel
115 118 P - Indeterminate cytology in breast screening: correlation of mammography with histology Richards, P.J.
 1996
 32 S1 p. S23-
1 p.
 artikel
116 103 P - Induction of expression of tumour TGFβ2 MRNA is associated with response to tamoxifen in breast cancer MacCallum, J.
 1996
 32 S1 p. S21-
1 p.
 artikel
117 159 P - Induction of LNCaP tumor growth in vivo by human prostate fibroblasts from different zonal origin Thalmann, G.N.
 1996
 32 S1 p. S31-
1 p.
 artikel
118 172 P - Inhibition of BCL-2 by antisense oligonucleotides reduces tumor size and reduces chemotesistance of human melanoma in SCID mice Jansen, B.
 1996
 32 S1 p. S35-
1 p.
 artikel
119 12 P - Interleukin-8 (IL-8), interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), soluble tnf receptors (sTNFR) 75 and 55 after BCG therapy of urothelial cancer (TCC): kinetics over 6 instillations Thalmann, G.N.
 1996
 32 S1 p. S3-
1 p.
 artikel
120 55 P - Intraoperative imprint cytology in the diagnosis of lung tumours Staniszewski, A.
 1996
 32 S1 p. S11-
1 p.
 artikel
121 111 P - Is age a major factor in breast cancer patients management? Muñoz, M.
 1996
 32 S1 p. S22-
1 p.
 artikel
122 5 P - Is P 53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancers? Eid, H.
 1996
 32 S1 p. S2-
1 p.
 artikel
123 40 P - Localized malignant mesothelioma in hungary Károlyi, A.
 1996
 32 S1 p. S8-
1 p.
 artikel
124 141 P - Local recurrence after total rectal resection, mesorectum excision and coloendoanal anastomosis for treatment of low rectal cancer Leo, E.
 1996
 32 S1 p. S27-
1 p.
 artikel
125 97 P - Low dose, short-term adjuvant chemotherapy in stage I hormone receptor negative breast cancer Jakesz, R.
 1996
 32 S1 p. S20-
1 p.
 artikel
126 63 P - Manual leukapheresis in life threatening blast transformation Dimitrijević, Gradimir
 1996
 32 S1 p. S13-
1 p.
 artikel
127 152 P - MDR1 transcripts do not indicate long-term prognosis in primary colorectal carcinomas Zöchbauer, S.
 1996
 32 S1 p. S29-
1 p.
 artikel
128 176 P - Measurement of stress dimension in cancer patients Siwek, B.
 1996
 32 S1 p. S35-
1 p.
 artikel
129 52 P - Mitomycin C. vlnorelbine. carboplatin and Gm-CSF for treatment of advanced non small cell lung carcinoma (NSCLC) Schenk, T.
 1996
 32 S1 p. S10-
1 p.
 artikel
130 72 P - Modified C/MOPP-A/EBV in HD patients Płuż;ańska, A.
 1996
 32 S1 p. S14-
1 p.
 artikel
131 85 P - Modulation of decreased adhesion molecule expression on breast cancer cell lines in vitro Budinsky, A.C.
 1996
 32 S1 p. S18-
1 p.
 artikel
132 26 P - Monitoring of neurotoxicity of taxanes Malayeri, R.
 1996
 32 S1 p. S6-
1 p.
 artikel
133 92 P - MRP and MDR1 Gene expression in primary breast carcinomas Filipits, M.
 1996
 32 S1 p. S19-
1 p.
 artikel
134 83 P - Ocular toxicity of tamoxifen Bonagura, S.
 1996
 32 S1 p. S17-
1 p.
 artikel
135 13 P - Ontogeny of human natural killer (NK) cells: cytolytic mechanisms Vaz, F.
 1996
 32 S1 p. S3-
1 p.
 artikel
136 73 P - Oral idarubicin (OIDA) in elderly patients (pts) with acute myelogenous Leukemia (AML): An opportunity? Visentin, F.C.A.
 1996
 32 S1 p. S14-
1 p.
 artikel
137 171 P - Orthotopic liver transplantation (LTX) +/- neoadjuvant chemo-therapy in unresectable hepatocellular hepatoma (HCC) - a prospective randomized trial Gnant, M.
 1996
 32 S1 p. S34-
1 p.
 artikel
138 30 P - Our experiences with ifosfamide Priatelová, I.
 1996
 32 S1 p. S6-
1 p.
 artikel
139 164 P - Ovarian cancer in bulgaria Iltcheya, M.
 1996
 32 S1 p. S32-
1 p.
 artikel
140 43 P - Paclitaxel/cisplatin in stage IIIB/IV non-small-cell lung cancer Krajnik, G.
 1996
 32 S1 p. S9-
1 p.
 artikel
141 94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer Greinix, H.T.
 1996
 32 S1 p. S19-
1 p.
 artikel
142 45 P - Parameters of immunological response in lung cancer patients Swierkocki, K.
 1996
 32 S1 p. S9-
1 p.
 artikel
143 91 P - Periductal mastitis and mammary duct ectasia - two stages of the same disease? Diaconu, C.
 1996
 32 S1 p. S19-
1 p.
 artikel
144 135 P - Phase I/II trial of epirubicin (EPI) and high dose tamoxifen (TAM) as a potential modulator of multidrug resistance in advanced hepatocellular carcinoma (HCC) Budinsky, A.
 1996
 32 S1 p. S26-
1 p.
 artikel
145 170 P Phase II trial of lnterferon-γ (LFN-γ)/interleukln-2 (1L-2) for advanced renal cell carcinoma (RCC) Djavanmard, M.P.
 1996
 32 S1 p. S34-
1 p.
 artikel
146 101 P - Plasminogen activator inhibitor type 1 as a prognostic factor in breast cancer Fernö, Mårten
 1996
 32 S1 p. S20-
1 p.
 artikel
147 60 P - Preclinical pharmacology and drug synergism studies of peg-asparaginase (PEG-ASNase) and cytarabine (ara-C) in leukemia cell lines Periclou, A.P.
 1996
 32 S1 p. S12-
1 p.
 artikel
148 104 P - Predictive factors for response to neoadjuvant chemotherapy in operable breast cancer > 3 cm Massidda, B.
 1996
 32 S1 p. S21-
1 p.
 artikel
149 95 P - Preoperative, neoadjuvant chemotherapy leads to breast conserving surgery in locally advanced breast cancer Gnant, M.
 1996
 32 S1 p. S19-
1 p.
 artikel
150 75 P - Primary extranodal non-hodgkin lymphoma of head and neck: the experience in twenty-eight patients Sahin, B.
 1996
 32 S1 p. S15-
1 p.
 artikel
151 145 P - Prognostic factors for stomach and colorectal cancer. The analysis from population - based cancer registry Pawlega, J.
 1996
 32 S1 p. S28-
1 p.
 artikel
152 4 P - Prognostic value of molecular alterations of p53 and K-ras genes in non-small cell lung cancer de Anta, J.M.
 1996
 32 S1 p. S1-
1 p.
 artikel
153 77 P - Pulmonary impairment in long-survivors of hodgkin's disease (HD) Sorarù, M.
 1996
 32 S1 p. S15-
1 p.
 artikel
154 148 P - Relationship between educational degree and knowledge/adherence to prevention modalities for colorectal cancer: data from 3738 Robbiati, S.F.
 1996
 32 S1 p. S29-
1 p.
 artikel
155 2 P - Relationship between rTNF α-, Apoptosis- and Multidrug-Resistance in vitro Berger, W.
 1996
 32 S1 p. S1-
1 p.
 artikel
156 126 P - Relationships between the time of occurrence of pulmonary metastases and the volume of primary tumour in breast cancer Suwinski, R.
 1996
 32 S1 p. S24-
1 p.
 artikel
157 107 P - Results of a randomized adjuvant breast cancer trial comparing a conventional with a perioperative start of chemotherapy Michl, L.
 1996
 32 S1 p. S21-
1 p.
 artikel
158 149 P - Role of radiotherapy (RT) in the treatment of resectable gastric cancer Skoropad, V.
 1996
 32 S1 p. S29-
1 p.
 artikel
159 76 P - Salvage treatment of previously treated patients with advanced stage Hodgkin's disease with CCNU, etoposide and prednimustine (CEP) therapy Schneider, T.
 1996
 32 S1 p. S15-
1 p.
 artikel
160 179 P - Second line chemotherapy in HIV-related non-hodgkin's lymphoma: Evidence of activity of a combination of VP16, mitoxantrone and prednimustine in relapsed patients Errante, D.
 1996
 32 S1 p. S37-
1 p.
 artikel
161 27 P - Second line chemotherapy with modulation of drug resistance in patients with advanced soft tissue sarcoma Michl, I.
 1996
 32 S1 p. S6-
1 p.
 artikel
162 67 P - Second-line treament of hodgkin’ disease with abvd combination chemotherapy Monár, Zs.
 1996
 32 S1 p. S13-
1 p.
 artikel
163 129 P - Serum CA 15-3 in node-negative breast cancer: a marker of prognostic significance? Wojtacki, J.
 1996
 32 S1 p. S25-
1 p.
 artikel
164 115 P - Serum level of aminoterminal propeptide of type III procaollagen (PIIINP) - new prognostic factor in operable breast cancer?. Preliminary report Poborski, W.A.
 1996
 32 S1 p. S23-
1 p.
 artikel
165 93 P - Study on sentinel nodes in breast cancer using Lymphoscintigraphy and radio-guided probe Galimberti, V.
 1996
 32 S1 p. S19-
1 p.
 artikel
166 48 P - Surgery following neoadjuvant chemotherapy (cisplatin, vepesid) in locally advanced non-small cell lung cancer Paprota, K.
 1996
 32 S1 p. S10-
1 p.
 artikel
167 56 P - Survival after surgical treatment of brain metastases from lung cancer: 1984–1995 Stempniewicz, M.
 1996
 32 S1 p. S11-
1 p.
 artikel
168 168 P Taxol as radiosensitizer in vitro: is the G2/M block a prerequisite? Bujor, L.
 1996
 32 S1 p. S34-
1 p.
 artikel
169 127 P - TGF-b reduces nitric oxide production BT tumour associated macrophages Toomey, D.
 1996
 32 S1 p. S25-
1 p.
 artikel
170 112 P - The impact of diagnosis and treatment on the quality of life (QOL) in breast cancer patients Ozyilkan, O.
 1996
 32 S1 p. S22-
1 p.
 artikel
171 65 P - The prognostic relevance of the substages of pathological stage III hodgkin's disease (HD) and its clinico-therapeutic implications Magrini, S.M.
 1996
 32 S1 p. S13-
1 p.
 artikel
172 119 P - The relative expression of EGFR and p185c-erbB-2 defines the speed of breast tumour cell proliferation Robertson, K.
 1996
 32 S1 p. S23-
1 p.
 artikel
173 25 P The role of a cytoreductive surgery in nonseminomatus germ cell tumor patients with small retroperitoneal mass after induction cemoterapy Karpov, S.A.
 1996
 32 S1 p. S5-
1 p.
 artikel
174 47 P - The role of basic fibroblast growth factor (bFGF) in human non small cell lung cancer (NSCLC) Mohr, Th.
 1996
 32 S1 p. S9-
1 p.
 artikel
175 41 P - The role of histamine H1 - receptors in the neuromodulation in human lung adenocarcinoma Kondratenko, T.
 1996
 32 S1 p. S8-
1 p.
 artikel
176 19 P - The side effects of paclitaxel in solid tumors Cypro, Petr
 1996
 32 S1 p. S4-
1 p.
 artikel
177 84 P - Tissue expression and serum levels of HER-2/neu in patients with breast cancer Brodowicz, T.
 1996
 32 S1 p. S17-
1 p.
 artikel
178 155 P - Tissue polypeptide specific antigen (TPS) - a hormone-independent marker for tumor activity in androgen - treated prostate cancer (PC) Kramer, G.
 1996
 32 S1 p. S30-
1 p.
 artikel
179 99 P - Treatment of advanced breast cancer with vinorelbine (VLB), fluorouracil (FU), l-leucovorin (LLV) and human granulocyte colony-stimulating factor (GCSF) Kornek, G.V.
 1996
 32 S1 p. S20-
1 p.
 artikel
180 174 P - Treatment, result and follow-up of jaw,s sarcomas krodotov, M.
 1996
 32 S1 p. S35-
1 p.
 artikel
181 66 P - Twenty years’ experience with hodgkin's disease (HD) at the university of florence: the remaining challenge after a “success story” Magrini, S.M.
 1996
 32 S1 p. S13-
1 p.
 artikel
182 105 P - Two intense adjuvant regimens in high risk breast cancer patients who received neoadjuvant Massidda, B.
 1996
 32 S1 p. S21-
1 p.
 artikel
183 86 P - Usefulness of color doppler in assessing breast intracystic or intraductal solid lesions Cassano, E.
 1996
 32 S1 p. S18-
1 p.
 artikel
                             183 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland